Rebecca Wong


Princess Margaret Cancer Centre
610 University Avenue, Toronto, Ontario Canada M5G 2M9
Clinical Interests
Clinical trials design, Outcomes research, Systematic reviews, Clinical guidelines development, Patient preferences: measurement and application, Gastrointestinal malignancies, Palliative radiotherapy
Please contact Faculty Member for more information


  • MBChB, Sheffield University Medical School
  • FRCPC, Radiation Oncology
  • MSc, Design Measurement and Evaluation, McMaster University

Research Synopsis

  • Experiences of rectal cancer patients undergoing aggressive multi-modal treatment
  • Delays in radiotherapy for cancer
  • A Phase III study comparing Ondansetron and decadron vs. Ondansetron and placebo in the prophylaxis of radiation induced emesis
  • A Phase I study of 5FU and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with advanced or recurrent rectal cancer
  • A Phase III double blind randomised study to compare the effectiveness in pain control for bony metastasis using combined intravenous bolus Bisphosphonates (Pamidronate) and radiotherapy versus radiotherapy and placebo
  • A phase I/II study to evaluate toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia in patients with unresectable/incurable carcinoma of the esophagus
  • Determination of the minimal clinically important effect size for pain relief. Evaluation of remineralizaton due to radiotherapy for breast cancer patients with bony metastases using Computerized Tomography (CT) density measurements



Vice Chair, Education, Department of Radiation Oncology, University of Toronto
Professor, Department of Radiation Oncology, University of Toronto
Staff Radiation Oncologist, Princess Margaret Hospital/University Health Network
Associate, Department of Health Policy, Management & Evaluation, University of Toronto